Company Filing History:
1 out of 23 
1 out of 5,101 
1 out of 4 Years Active: 2020
Title: The Innovative Contributions of Guillaume Dolla
Introduction
Guillaume Dolla is a notable inventor based in Valbonne, France. He has made significant contributions to the field of medical research, particularly in the area of nephrology. His work focuses on the prognosis and monitoring of membranous nephropathy, a condition that affects the kidneys.
Latest Patents
Guillaume Dolla holds a patent titled "Prognosis and monitoring of membranous nephropathy based on the analysis of PLA2R1 epitope profile." This patent discloses a method for assessing the prognosis of idiopathic membranous nephropathy using a body fluid sample from a human subject. The method involves profiling PLA2R1 epitopes recognized by autoantibodies in the sample. It also analyzes PLA2R1 epitope spreading among three PLA2R1 domains, which are recognized by anti-PLA2R1 autoantibodies. Notably, two of these domains are more closely associated with active idiopathic membranous nephropathy and are likely linked by a mechanism of epitope spreading.
Career Highlights
Throughout his career, Guillaume Dolla has worked with esteemed institutions such as Université de Nice Sophia Antipolis and the Centre National de la Recherche Scientifique. His research has contributed to a deeper understanding of kidney diseases and their underlying mechanisms.
Collaborations
Guillaume has collaborated with notable colleagues, including Vincent Louis Marie Esnault and Barbara Polski. These collaborations have further enriched his research and innovation in the field.
Conclusion
Guillaume Dolla's innovative work in the prognosis and monitoring of membranous nephropathy showcases his dedication to advancing medical research. His contributions are significant in improving the understanding and treatment of kidney diseases.